Affymetrix (NASDAQ:AFFX) was a bit of a puzzling stock today when we saw it had hit a 52-week low after a proposed $250 million convertible note offering. After the near-10% haircut, this has a…
GlaxoSmithKline’s (GSK) diabetes drug Avandia has such frightening side effects that the FDA will probably make it carry a "black box" label. Studies have found that the treatment can increase risk of heart attack.…
Several studies which showed that stents could cause blood clotting in the heart have done significant damage to the revenue for those products at Boston Scientific (BSX) and Johnson & Johnson (JNJ). BSX trades…
It has been a bloody and bitter fight. Merck’s (MRK) pain killer Vioxx has been alleged to cause heart problems and worse. The drug hit the market in 1999 and was pulled in 2004.…
Allscripts Healthcare Solutions Inc. (NASDAQ:MDRX) is trading at a new 52-week low after a disaster earnings report this afternoon. Non-GAAP adjusted earnings for the quarter ended September 30, were $6.7 million, or $0.11 per…
Geron Corp. (NASDAQ:GERN) is trading up in pre-market activity on news that would have been much more eagerly received back in the emergence of stem cell news. Geron announced that data shows its human…
GlaxoSmithKline’s (NYSE:GSK) Avandia sales might not just weak after the reports of cardiovascular risks were reported. If this research is accurate, the sales might be on the path to vanishing. We have not conducted…
GTx, Inc. (NASDAQ: GTXI) is seeing shares trade sharply higher on a collaboration pact with Merck (NYSE: MRK). The biotech and drug giant pact is for research and development and a strategic collaboration for…
Novacea, Inc. (NASDAQ:NOVC) has ended its Phase III ASCENT-2 clinical trial of Asentar(TM) (DN-101). Unfortunately this is Novacea’s lead investigational cancer therapy for the treatment of patients with androgen-independent prostate cancer. The trial halt…
Plavix from Bristol-Myers (BMY) is the medical drug-thinner of choice. According to CNN Money, sales of the drug "totaled $3.4 billion in sales during the first nine months" Now Eli Lilly (LLY) has a…
Pfizer (PFE) has a new ad campaign for its erectile dysfunction drug Viagra. The marketing message is all over TV and in little video clips online. Reuters.com appears to have one of the ads…
On tonight’s MAD MONEY on CNBC, Jim Cramer said he has a small speculative stock that got crushed. Nastech Pharmaceutical Inc. (NASDAQ:NSTK) is supposed to win from an intranasal delivery system, and it is…
Some traders might bother peering at the losses on Medarex (NASDAQ:MEDX), but all we are looking at for the time being is the forward study data and the company’s use of cash and burn…
WellCare Health Plans (NYSE:WCG) is falling under class action pressure and more investigations. Unfortunately the company has yet to admit to or to convince Wall Street that it has a full grasp of the…
Shares of WellCare Health Plans (NYSE:WCG) are up marginally in pre-market trading Monday. Jefferies & Co. issued a report that, despite the FBI raids, the company probably won’t lose its Medicare contracts even though…